Biogen Inc. (BIIB) vs Centene Corporation (CNC)
CNC leads on 7 of 13 compared metrics.
A side-by-side comparison of Biogen Inc. and Centene Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Not enough overlapping price history to compare BIIB and CNC.
BIIB vs CNC: by the numbers
- •CNC is the larger company ($32.19B vs $29.53B market cap).
- •BIIB is profitable (13.92% net margin) while CNC runs a net loss (-3.25%).
- •CNC grew revenue faster over the past five years (11.48% vs -4.80% CAGR).
Which is better, BIIB or CNC?
Metric tally: BIIB 6 · CNC 7It depends on what you're optimizing for:
GrowthCNC(faster 5Y revenue CAGR)
QualityBIIB(higher ROIC)
Valuation
| Metric | BIIB | CNC |
|---|---|---|
| P/E ratio | 21.42 | — |
| Forward P/E | 12.23● | 14.49 |
| P/S ratio | 3.01 | 0.16● |
| P/B ratio | 1.59 | 1.51● |
| EV / EBITDA | 12.16 | — |
| FCF yield | 8.83% | 19.65%● |
Profitability
| Metric | BIIB | CNC |
|---|---|---|
| Gross margin | 69.77%● | 14.93% |
| Operating margin | 15.65%● | -3.68% |
| Net margin | 13.92%● | -3.25% |
| ROE | 7.36%● | -30.07% |
| ROIC | 6.62%● | -13.41% |
Growth (annualized)
| Metric | BIIB | CNC |
|---|---|---|
| Revenue CAGR (5Y) | -4.80% | 11.48%● |
| EPS CAGR (5Y) | -18.67% | 14.68%● |
| FCF CAGR (5Y) | -3.59% | 5.28%● |
| Total return CAGR (5Y) | -12.79% | -1.64%● |
Frequently asked
- Which is better, BIIB or CNC?
- It depends on your goal. growth: CNC (faster 5Y revenue CAGR); quality: BIIB (higher ROIC). Across all compared metrics, CNC leads 7 to 6.
- Which has grown faster, BIIB or CNC?
- Over the past five years, CNC grew revenue faster — BIIB at a -4.80% CAGR versus CNC at 11.48%.
- Is BIIB or CNC more profitable?
- BIIB runs the higher net margin — BIIB at 13.92% versus CNC at -3.25%.
- Which has been the better investment, BIIB or CNC?
- Over the past 10-year, CNC delivered the higher annualized total return — BIIB at -2.05% versus CNC at 6.74%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Biogen P/E ratioCentene P/E ratioBiogen dividend yieldCentene dividend yieldBiogen ROECentene ROEBiogen operating marginCentene operating marginBiogen revenue growthCentene revenue growthBiogen free cash flowCentene free cash flow
Biogen & Centene appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.